Latest filing published 18 Aug 2026 for Verrica Pharmaceuticals Inc., €88k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jayson Rieger is a declared insider of Verrica Pharmaceuticals Inc., with filings sourced from SEC (Form 4). The record holds 4 filings, for trades running from 22 November 2024 to 17 August 2026.
Every open-market trade on record is a purchase: 4 purchases worth €456k, and no sale. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 2 purchases and no sales on the market.
A typical purchase (the median) is worth €88k. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
On 18 August 2026 came the latest disclosure, an open-market purchase for €88k in Verrica Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations